Does RABEPRAZOLE Cause Focal segmental glomerulosclerosis? 17 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Focal segmental glomerulosclerosis have been filed in association with RABEPRAZOLE (Rabeprazole Sodium). This represents 0.2% of all adverse event reports for RABEPRAZOLE.
17
Reports of Focal segmental glomerulosclerosis with RABEPRAZOLE
0.2%
of all RABEPRAZOLE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From RABEPRAZOLE?
Of the 17 reports.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RABEPRAZOLE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does RABEPRAZOLE Cause?
Chronic kidney disease (4,773)
Renal failure (3,135)
Acute kidney injury (2,545)
End stage renal disease (1,295)
Tubulointerstitial nephritis (1,125)
Death (857)
Drug ineffective (732)
Dyspnoea (423)
Gastrooesophageal reflux disease (416)
Headache (387)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which RABEPRAZOLE Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
RABEPRAZOLE vs RACECADOTRIL
RABEPRAZOLE vs RADIATION THERAPY
RABEPRAZOLE vs RADIUM RA-223 DICHLORIDE
RABEPRAZOLE vs RALOXIFENE
RABEPRAZOLE vs RALTEGRAVIR